Breakfast & Biotech with Biocytogen
Biocytogen eagerly invites fellow industrial partners and colleagues to join us for a Biotech and Breakfast session at the MassBio Hub. About this event Therapeutic…
Read more
Webinar: Preclinical Pharmacokinetics (PK) and Pharmacodynamics (PD) Evaluation with Biocytogen
Our webinar “Preclinical Pharmacokinetics (PK) and Pharmacodynamics (PD) Evaluation with Biocytogen" was live on Sep 29, 2022 at 1PM EDT. An understanding of the exposure-response…
Read more
Webinar: Preclinical Models to Investigate NK Cell-Targeted Immunotherapies
Our webinar “Preclinical Models to Investigate NK Cell-Targeted Immunotherapies" was live on Aug 31, 2022 at 1PM EDT. In this webinar, we Reviewed the mechanisms…
Read more
18th International SCBA Symposium
Attend the meeting Talk to us The Society of Chinese Bioscientists in America (SCBA) is a non-profit organization founded by a few prominent and enthusiastic bioscientists…
Read more
Basic Cardiovascular Sciences Scientific Sessions 2022
Attend the meeting Talk to us at booth 9 The annual BCVS Scientific Sessions is one of largest meetings in the world dedicated to fundamental…
Read more
Tumor Models Boston 2022
Attend the meeting Talk to us Meet our expert scientists to learn about our recent advances in preclinical drug evaluation, which includes new humanized animal…
Read more
EACR 2022 Congress
EACR 2022 is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest…
Read more
Biocytogen Europe Innovation Center Team to Present at AET-EU 2022, Introducing Project Integrum, TCR-mimic Platform and YH012
Beijing and Heidelberg, June 3, 2022 -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") today announced 3 poster presentations for two novel fully human antibody platforms…
Read more
Webinar: Next-Generation B-NDG Mice: Improved Immunodeficient Models for Research and Discovery
Our webinar “Next-Generation B-NDG Mice: Improved Immunodeficient Models for Research and Discovery" was live on June 22, 2022 at 1PM EDT. In this webinar, we…
Read more
Biocytogen/Eucure Biopharma to Present Clinical Data from YH003 (anti-CD40 mAb) and YH001 (anti-CTLA-4 mAb) Trials at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Beijing, China, May 24, 2022 /PRNewswire/ -- Eucure Biopharma, a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen"), today announced that it will…
Read more